Barclays
MMED

Barclays’s MiniMed Group Inc MMED Stock Holding History

Barclays’s Portfolio MMED Stock Details MMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128K Sell
8,573
-49,920
-85% -$658K ﹤0.01% 3938
2026
Q1 		$873K Buy
+58,493
New +$965K ﹤0.01% 2831

Other funds holding MMED

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barclays's MMED Position: Q2 2026 in Review

Barclays reduced its MiniMed Group Inc (MMED) stake by 85% in Q2 2026, selling an estimated $658K and leaving 8,573 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #3938.

Barclays first reported a position in MMED in Q1 2026 and has held it in 2 quarters since. The position peaked at $873K in Q1 2026. 98 funds tracked by Wall St. Rank hold MMED as of Q2 2026.

  • Barclays held 8,573 shares of MiniMed Group Inc worth $128K as of Q2 2026.
  • Barclays sold 49,920 MiniMed Group Inc shares in Q2 2026, an estimated $658K.
  • MiniMed Group Inc made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3938 holding.
  • Barclays first reported a position in MiniMed Group Inc in Q1 2026 and has held it in 2 quarters since.
  • Barclays's MiniMed Group Inc position peaked at $873K in Q1 2026.
  • 98 funds tracked by Wall St. Rank held MiniMed Group Inc as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.